diclofenac potassium + nimesulide
ApprovedWithdrawn 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Upper Respiratory Tract Infections
Conditions
Upper Respiratory Tract Infections
Trial Timeline
Apr 1, 2011 → —
NCT ID
NCT01257126About diclofenac potassium + nimesulide
diclofenac potassium + nimesulide is a approved stage product being developed by Novartis for Upper Respiratory Tract Infections. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01257126. Target conditions include Upper Respiratory Tract Infections.
What happened to similar drugs?
5 of 14 similar drugs in Upper Respiratory Tract Infections were approved
Approved (5) Terminated (0) Active (9)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01257126 | Approved | Withdrawn |
Competing Products
20 competing products in Upper Respiratory Tract Infections